ARKA Clinical Decision Support is designed to meet all four criteria for Non-Device CDS under FD&C Act §520(o)(1)(E) and FDA's January 2026 final guidance on Clinical Decision Support Software. Recommendations support, not replace, the clinician's judgment. Every recommendation is anchored in a published guideline or peer-reviewed source, with the basis available for independent review. CLIN emphasizes imaging appropriateness at order entry.
This recommendation is intended to support, not replace, clinical judgment. It is generated by ARKA, software designed to meet the four criteria for Non-Device Clinical Decision Support under FD&C Act §520(o)(1)(E) and FDA's final guidance on Clinical Decision Support Software (January 2026). The clinician is responsible for the final decision.
AIIE Evidence
Pelvic ultrasound first for female pelvic pain — reserve CT for suspected GI sources and MRI for problem-solving.
Transvaginal and transabdominal ultrasound is the first imaging study for female pelvic pain, evaluating ovarian cysts, torsion, tubo-ovarian abscess, and uterine pathology without radiation. CT and MRI are problem-solving studies, not first steps.
The AIIE synthesis above is ARKA-authored; the sources below are the underlying external literature.
American College of Radiology · 2024
Obstetrics & Gynecology · 2018doi:10.1097/AOG.0000000000002560